Luxembourg Cohort of Positive Patients for COVID-19: a Stratification Study to Predict Patient Prognosis

CompletedOBSERVATIONAL
Enrollment

1,366

Participants

Timeline

Start Date

May 4, 2020

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions
Covid19
Interventions
BIOLOGICAL

Biological sampling

For every symptomatic adult tested positive by RTqPCR, up to 45 mL of blood will be taken, nasopharyngeal and oropharyngeal swab will be performed, an induced sputum and a stool samples will be recovered at the inclusion. As follow-up, 3 weeks after inclusion, up to 45 mL of blood will be taken and a new induced sputum will be recovered.

Trial Locations (1)

Unknown

Luxembourg Institute of Health, Luxembourg

All Listed Sponsors
collaborator

Centre Hospitalier du Luxembourg

OTHER

collaborator

Hopitaux Robert Schuman (Luxembourg)

UNKNOWN

collaborator

Laboratoire National de Santé (Luxembourg)

UNKNOWN

collaborator

University of Luxembourg

OTHER

lead

Luxembourg Institute of Health

OTHER_GOV

NCT04380987 - Luxembourg Cohort of Positive Patients for COVID-19: a Stratification Study to Predict Patient Prognosis | Biotech Hunter | Biotech Hunter